drugset / Trial / NCT00846014
Asthma Exacerbation and Helium-3 MRI
Withdrawn
University of Massachusetts, Worcester
NaSingle-groupOpen-labelDiagnostic
Summary
The goal of this research is to use Helium-3 MRI to see the changes in airflow of the lungs at different times of an attack. These three stages are immediately after the attack, 1 month later and 4-6 months later.
Timeline
- Start
- 2009-01
- Primary completion
- 2011-08
- Completion
- 2011-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Helium-3 | Diagnostic / imaging agent | 333 ml | Inhaled |